12 December 2022 - Quantifying the effect of a treatment on a clinical outcome—causal inference—requires the comparison of outcomes under different ...
5 December 2022 - In medical research, data sharing facilitates discovery and innovation, transparency, and reproducibility, and, ultimately, trust in ...
1 December 2022 - At a time when many Americans are clamouring for more transparency into prescription drug pricing, one ...
10 October 2022 - EMA and the Heads of Medicines Agencies in the EU Member States are moving ahead with ...
4 August 2022 - As U.S. monkeypox cases rise, U.S. health agencies in a medical journal article published on Wednesday ...
28 July 2022 - The Big Data Steering Group set up by EMA and the Heads of Medicines Agencies has ...
12 July 2022 - EMA has launched a pilot project to assess whether the analysis of ‘raw data’ from clinical ...
5 May 2022 - NICE's expert group RAPID C-19, set up to ‘to ensure safe and timely patient access to treatments ...
19 April 2022 - The criteria for supply related data established by IQWiG in 2020 were positively received in science. ...
24 February 2022 - An interesting letter to the Editor of the BMJ from the Head of Drug Assessment at ...
18 February 2022 - Historically, the US FDA has considered much of the oversight of clinical trials, interactions with companies, and ...
11 February 2022 - The World Health Organization Eleventh Revision of the International Classification of Diseases (ICD-11) has now come ...
13 February 2022 - The FDA has the awesome responsibility to protect public health by ensuring the safety and effectiveness of ...
27 January 2022 - Pfizer wants to intervene in a Texas federal lawsuit seeking information from the U.S. FDA used ...
19 January 2022 - Data should be fully and immediately available for public scrutiny ...